🔗 Share this article

This year's prestigious award in medical science was granted for transformative discoveries that illuminate how the immune system targets dangerous infections while protecting the body's own cells.

Three renowned researchers—from Japan Shimon Sakaguchi and US experts Dr. Brunkow and Fred Ramsdell—received this honor.

The work uncovered specialized "security guards" within the defense system that remove malfunctioning immune cells that could harming the body.

These findings are now enabling innovative therapies for immune disorders and malignancies.

The winners will share a monetary award worth 11m SEK.

Decisive Discoveries

"The research has been essential for comprehending how the body's defenses operates and why we don't all suffer from severe self-attack conditions," stated the head of the Nobel Committee.

The team's studies address a fundamental mystery: How does the defense system protect us from numerous invaders while keeping our own tissues intact?

The immune system employs immune cells that scan for signs of disease, including viruses and bacteria it has not met before.

These defenders utilize sensors—known as receptors—that are generated randomly in a vast number of combinations.

That gives the defense network the ability to fight a wide array of threats, but the randomness of the process unavoidably creates white blood cells that may attack the body.

Protectors of the Immune System

Scientists previously knew that a portion of these harmful defense cells were destroyed in the thymus—where white blood cells develop.

This year's Nobel Prize honors the discovery of regulatory T-cells—described as the immune system's "peacekeepers"—which patrol the system to disarm any immune cells that assault the healthy cells.

It is known that this process fails in self-attack conditions such as type-1 diabetes, MS, and rheumatoid arthritis.

A Nobel panel stated, "These discoveries have established a novel area of research and spurred the creation of new treatments, for instance for tumors and autoimmune diseases."

In cancer, T-regs prevent the body from fighting the tumor, so studies are aimed at lowering their quantity.

For self-attack disorders, experiments are testing increasing T-reg cells so the organism is no longer under attack. A comparable approach could also be useful in minimizing the chances of organ transplant rejection.

Innovative Experiments

Prof Shimon Sakaguchi, of a Japanese institution, performed experiments on mice that had their immune gland removed, causing self-attack conditions.

He showed that introducing defense cells from other animals could prevent the disease—suggesting there was a system for preventing defenders from attacking the host.

Mary Brunkow, affiliated with the a research center in Seattle, and Dr. Ramsdell, currently at a biotech firm in San Francisco, were investigating an genetic immune disorder in rodents and humans that resulted in the discovery of a gene vital for the way T-regs operate.

"The pioneering research has revealed how the body's defenses is controlled by regulatory T cells, preventing it from accidentally attacking the healthy cells," said a prominent physiology specialist.

"This research is a striking illustration of how fundamental biological research can have far-reaching implications for human health."